Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

Most of us are aware of the concept of drug side effects, which can be either negative or positive. The goal of any drug ...

Even a hidden spice shelf attachment to put that seemingly dead space in your cabinet to good use. View Entire Post › ...

An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11, 2023. [Photo: Brendan ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

Viking says an early-stage study of its obesity pill VK2735 showed adults on the highest dosage lost 8.2% of their body ...

Shares of Viking Therapeutics (NASDAQ:VKTX) jumped 22% Monday morning after the biotech firm reported promising results for ...

AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial.

A reboot of Sylvester Stallone’s action classic “Cliffhanger” is currently in production, but the film will look a lot different from the package initially announced nearly 18 months ago.

A reboot of Sylvester Stallone’s 1993 thriller ‘Cliffhanger’ will star Lily James and Pierce Brosnan Rocket Science;StudioCanal/Shutterstock Lily James is ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, will be presented at ...